⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GLSI News
Greenwich LifeSciences, Inc.
Greenwich LifeSciences Announces Approval to Expand FLAMINGO-01 into the United Kingdom
globenewswire.com
GLSI
Greenwich LifeSciences Provides Clinical Updates on FLAMINGO-01
globenewswire.com
GLSI
Greenwich LifeSciences Announces European Approval for Combining Both HLA Populations in FLAMINGO-01
globenewswire.com
GLSI
Greenwich LifeSciences Announces European Approval for Use of Commercially Manufactured GP2 in FLAMINGO-01
globenewswire.com
GLSI
Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026
globenewswire.com
GLSI
Greenwich LifeSciences Provides Update Regarding Form 10-K Filing
globenewswire.com
GLSI
Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
globenewswire.com
GLSI
Greenwich LifeSciences Provides Update Regarding Form 10-K Filing
globenewswire.com
GLSI
Greenwich LifeSciences Announces Acceptance of Abstract at ASCO 2026
globenewswire.com
GLSI
Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
globenewswire.com
GLSI